UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,753,000 | +142.5% | 4,437,259 | +246.2% | 0.00% | – |
Q2 2022 | $723,000 | -42.6% | 1,281,673 | +13.9% | 0.00% | – |
Q1 2022 | $1,260,000 | -51.5% | 1,125,195 | -36.7% | 0.00% | – |
Q4 2021 | $2,597,000 | -38.6% | 1,778,809 | +26.2% | 0.00% | – |
Q3 2021 | $4,228,000 | -35.7% | 1,409,379 | -0.6% | 0.00% | – |
Q2 2021 | $6,579,000 | -30.7% | 1,417,933 | -10.4% | 0.00% | – |
Q1 2021 | $9,498,000 | +15.3% | 1,583,032 | +0.7% | 0.00% | – |
Q4 2020 | $8,240,000 | +48.0% | 1,572,487 | -2.3% | 0.00% | – |
Q3 2020 | $5,569,000 | -55.6% | 1,609,693 | +11.5% | 0.00% | – |
Q2 2020 | $12,534,000 | +91.3% | 1,443,995 | +27.8% | 0.00% | – |
Q1 2020 | $6,551,000 | -9.0% | 1,129,601 | +13.1% | 0.00% | – |
Q4 2019 | $7,202,000 | +18.6% | 998,808 | +0.4% | 0.00% | – |
Q3 2019 | $6,070,000 | -1.3% | 995,041 | +53.7% | 0.00% | – |
Q2 2019 | $6,149,000 | -2.0% | 647,197 | -16.3% | 0.00% | – |
Q1 2019 | $6,274,000 | -46.7% | 773,512 | +6.9% | 0.00% | -100.0% |
Q4 2018 | $11,765,000 | +220.0% | 723,520 | +220.6% | 0.00% | – |
Q3 2018 | $3,677,000 | +116.9% | 225,708 | +100.6% | 0.00% | – |
Q2 2018 | $1,695,000 | – | 112,532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
Leap Investments LP | 13,400 | $78,000 | 0.11% |
Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |